Literature DB >> 27388229

Comparison between objective and subjective benign paroxysmal positional vertigo: clinical features and outcomes.

Jae Yun Jung1, Se-Hyung Kim2.   

Abstract

CONCLUSIONS: Objective benign paroxysmal positional vertigo (O-BPPV) and subjective BPPV (S-BPPV) have similar demographic and clinical features. Canalith repositioning manoeuvres (CRMs) can be an effective treatment for patients with S-BPPV, and a diagnosis of positional nystagmus is not essential for considering CRMs. This study supports the use of CRMs as the primary treatment for S-BPPV.
OBJECTIVE: To examine differences in demographic and clinical features, as well as treatment outcomes, between O-BPPV and S-BPPV.
METHODS: The medical records of 134 patients with BPPV were reviewed for demographic characteristics, past medical history, associated symptoms, response to CRMs, interval between symptom onset and the first medical visit, and recurrence rate. The O-BPPV group (n = 101) comprised patients who experienced vertigo and accompanying autonomic symptoms, and showed typical nystagmus. The S-BPPV group (n = 33) comprised patients who, when subjected to a provoking manoeuvre, showed all of the classic BPPV symptoms but did not show nystagmus. All patients had at least 3 years of follow-up.
RESULTS: The demographics (age and sex ratio), past medical history, and associated symptoms were not significantly different between the two groups. Posterior semi-circular canal BPPV appeared more than twice as often as horizontal semi-circular canal BPPV in patients with S-BPPV. However, both canals were affected to a similar proportion in patients with O-BPPV, and the difference was marginally significant (p = 0.073). Overall improvement was better in O-BPPV than in S-BPPV; however, there was no significant difference. The total numbers of manoeuvres for recovery and the interval between symptom onset and the first medical visit also did not show any significant inter-group differences. During a 3-year follow-up, the recurrence rate was 13.8% for O-BPPV and 21.2% for S-BPPV.

Entities:  

Keywords:  Benign paroxysmal positional vertigo; canalolithiasis; nystagmus; repositioning manoeuvre

Mesh:

Year:  2016        PMID: 27388229     DOI: 10.1080/00016489.2016.1203990

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  6 in total

1.  Efficacy of Epley Maneuver on Quality of Life of Elderly Patients with Subjective BPPV.

Authors:  Uzdan Uz; Didem Uz; Gülden Akdal; Onur Çelik
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

2.  Efficacy of Epley Maneuver on Quality of Life of Elderly Patients with Subjective BPPV.

Authors:  Mehmet Emre Sivrice
Journal:  J Int Adv Otol       Date:  2020-04       Impact factor: 1.017

Review 3.  Benign Positional Paroxysmal Vertigo Treatment: a Practical Update.

Authors:  Marco Mandalà; Lorenzo Salerni; Daniele Nuti
Journal:  Curr Treat Options Neurol       Date:  2019-12-05       Impact factor: 3.598

4.  Short-Term Effect of Epley Maneuver as Treatment for Subjective Benign Paroxysmal Positional Vertigo.

Authors:  Erika Maria Celis-Aguilar; Cindy Anahí Medina-Cabrera; Luis Alejandro Torrontegui-Zazueta; Blanca Xóchitl Núñez-Millán; Karla Mariana Castro-Bórquez; Alejandra Obeso-Pereda; César Guillermo García-Valle; Carlos Andrey Ochoa-Miranda
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-01-20

5.  Negative Impact of Vestibular Suppressant Drugs on Provocative Positional Tests of BPPV: A Study from the Western Part of India.

Authors:  Jayanti K Gurumukhani; Dhruvkumar M Patel; Sudhir V Shah; Mukundkumar V Patel; Maitri M Patel; Anand V Patel
Journal:  Ann Indian Acad Neurol       Date:  2021-01-08       Impact factor: 1.383

6.  Disability perceived by primary care patients with posterior canal benign paroxysmal positional vertigo.

Authors:  Ricard Carrillo Muñoz; José Luis Ballve Moreno; Iván Villar Balboa; Yolanda Rando Matos; Oriol Cunillera Puertolas; Jesús Almeda Ortega; Estrella Rodero Perez; Xavier Monteverde Curto; Carles Rubio Ripollès; Noemí Moreno Farres; Austria Matos Mendez; Jean Carlos Gomez Nova; Marta Bardina Santos; Johan Josué Villarreal Miñano; Diana Lizzeth Pacheco Erazo; Anabella María Hernández Sánchez
Journal:  BMC Fam Pract       Date:  2019-11-13       Impact factor: 2.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.